Document is current
Any future updates will be listed below
-
Authors
Kocheise, Lorenz https://orcid.org/0000-0002-0036-2234
Kempski, Jan https://orcid.org/0000-0001-8867-5077
Tang, Yunhe https://orcid.org/0000-0003-4531-8701
Balcar, Lorenz https://orcid.org/0000-0002-6708-3061
Berger, Victoria
Tomczak, Miriam https://orcid.org/0009-0003-1551-3634
Gorgulho, Joao
Masood, Ramsha
Giehren, Franziska
Schmidt, Constantin https://orcid.org/0000-0002-3892-4255
Sutter, Jan P.
Fruendt, Thorben W. https://orcid.org/0000-0001-5777-1031
Pagani, Francesca
Wulf, Sophie
Kött, Julian https://orcid.org/0000-0003-2073-3909
Domanig, Saskia
Giannou, Anastasios
Bedke, Tanja
Lücke, Jöran https://orcid.org/0000-0002-6081-479X
Zhang, Tao
Zhang, Siwen
Machicote, Andres
Lohse, Ansgar W.
Alunni-Fabbroni, Marianna https://orcid.org/0000-0002-9710-1662
Ricke, Jens
Khaled, Najib Ben
Pinter, Matthias
Scheiner, Bernhard
Huber, Samuel
von Felden, Johann
Piseddu, Ignazio https://orcid.org/0000-0001-8331-9778
Schulze, Kornelius
-
Funding
Funding for this research was provided by:
Deutsche Krebshilfe
European Crohn's and Colitis Organisation
Novartis Foundation
Deutsche Forschungsgemeinschaft (546185154)
Werner Otto Stiftung
Wilhelm Sander-Stiftung
Bundesministerium für Bildung und Forschung (01EO2106)
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab
Journal Title: Annals of Hepatology
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2025.102138
Content Type: article
Copyright: © 2025 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.
